ISPOR Stands With Ukraine

Published Mar 2, 2022

Lawrenceville, NJ, USA—March 2, 2022—As a scientific and educational nonprofit and the leading professional society for health economics and outcomes research globally, ISPOR rarely comments on issues not directly related to healthcare. The unprecedented military attack on Ukraine, however, requires a Society response.

As we witness the horrific events unfolding in Ukraine, we are reminded of the importance of freedom of thought, independence, diversity, and collaboration—not simply as the foundation for science, but more importantly as the basis for human interaction. As a global scientific society, ISPOR condemns the aggression taking place in Ukraine. Our thoughts and prayers for strength are with the Ukrainian people during this dark time. ISPOR extends its support to our affected colleagues who are both important members of the global scientific community and our family.

ISPOR’s mission is to promote health economics and outcomes research excellence to improve decision making for health globally. It goes without saying that an unprovoked war on a democratic country impacts our Society’s commitment to global health. As we stand with Ukraine and our dear friends and colleagues in the region, we find comfort in a quote by Louis Pasteur, “Science and peace will triumph over ignorance and war.”

Those interested in resources to support and donate to the relief efforts may read about options below. ISPOR members can find resources to local outlets for donations on this Member Community.

###

 

Resources for Ukraine Support and Donations:

Related Stories

Landmark Analysis in Value in Health Uncovers Potential Research Efficiency Gains

Sep 15, 2025

Value in Health, the official journal of ISPOR announced the publication of a landmark scoping review that provides a comprehensive mapping of patient preference studies across key medical domains, revealing the first robust evidence base for advancing meta-analyses and benefit transfer methods in healthcare decision-making.

ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Sep 9, 2025

ISPOR announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Sep 3, 2025

Value in Health, the official journal of ISPOR announced the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×